For more information, availability and pricing options for sponsorship/exhibition opportunities at the event, please contact Jon Liong at firstname.lastname@example.org.
QuintilesIMS (NYSE:Q) is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles and IMS Health, QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes and enhanced clinical trial outsourcing through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial bringing clients a unique opportunity to realize the full potential of innovations and advance healthcare outcomes.
As a global leader in protecting individual patient privacy, QuintilesIMS uses healthcare data to deliver critical, real-world disease and treatment insights. Through a wide variety of privacy-enhancing technologies and safeguards, QuintilesIMS protects individual privacy while managing information to drive healthcare forward. These insights and execution capabilities help biotech, medical device, and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders in the development and approval of new therapies, identify unmet treatment needs and understand the safety, effectiveness and value of pharmaceutical products in improving overall health outcomes. To learn more, visit www.QuintilesIMS.com.
AMICULUM® is an independent, privately-owned healthcare communications agency founded in 2001. It comprises a cluster of 7 specialized agencies based in 8 locations worldwide in China, Singapore, United Arab Emirates, UK and the USA.
Using both traditional and digital approaches, we deliver specialist services including medical communications, clinical and commercial consultancy, healthcare learning and value communications to leading international pharmaceutical companies.
AMICULUM, as Mudskipper®, has had a presence in Shanghai since 2008, and operates in both Chinese and English. Together with colleagues in Singapore, we deliver services to clients throughout Asia and Australia.
A team from AMICULUM will be attending the China Medical Affairs Summit in Shanghai on 15-17 June 2016. We will be pleased to take the opportunity to discuss our services for medical affairs professionals and are looking forward to meeting you.
Fountain Medical Development
Fountain Medical Development Ltd. is a contract research organization (CRO) offering a full range of ICH GCP compliant clinical research services in China and East Asia. The FMD management team has decades of combined experience working with the world’s leading CROs and drug developers. In the Chinese CRO market, we fill the void of a service provider that balance high quality with moderate cost. Our extensive global experience in multiple therapeutic areas is unmatched by other local CROs, and our lower operational cost allows us to pass significant savings on to our clients. Fountain has completed more than 100 clinical trial projects, we have been in good partnership with more than 200 sites in Asia and we have enrolled more than 57000 patients in clinical trials. Fountain’s success includes undertaking pivotal international studies. Fountain is your trustworthy CRO Choice in Asia.
Huntsworth Health is a global family of best-in-class healthcare communications agencies that provide a full continuum of consulting and communications services to the healthcare and well-being industry, with access to 72 wholly-owned offices in 31 countries.
With a strong footprint in China, including a strategic alliance with BlueFocus Communication Group, our teams bring unparalleled medical excellence to develop integrated, strategically aligned solutions driven by scientific data and clinical evidence to support true brand value.
From insights and strategy to compelling content and flawless delivery, we draw on our global and local expertise to help our clients educate and engage stakeholders to inspire measureable behaviour change.
Together, we play a crucial role in helping brands thrive and make a relevant and meaningful contribution to human health.
For more information, please vist at http://hhealth.com
For pharmaceutical companies launching new drugs, finding out who to talk to has always been the number one priority. But the network of influencers has widened exponentially from the old model of “the top 100 doctors”. It now includes everyone from patient groups to charities, pharmacists to hospital managers.
Using a research-analyse-profile model, Thecosystems® let you see not just who are the most influential stakeholders in a particular disease, but also who else they are connected to and through which channels. Thecosystems is the brainchild of MMRG, a specialist stakeholder research consultancy. Launched in 1981, MMRG serves the needs of the global pharmaceutical industry, with many of the world's biopharmaceutical companies on its roster of clients. Our multidisciplinary team includes physicians, pharmacists, project managers and software specialists.